Skip to main content
All lobbying filings

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Lobbying for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · no change

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$3,428,860.00
What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • ANTHONY BUSH
    Previously held: Research Assistant, House Committee on Oversight and Reform, Majority Staff Personal Assistant to Rep. Elijah Cummings

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 5
  • Centers For Medicare and Medicaid Services (CMS)
  • Executive Office of the President (EOP)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 22
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 927
    Protecting Pharmacies in Medicaid Act
  • S 832
    EPIC Act of 2025
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S 882
    Patients Before Middlemen Act
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1040
    Drug Competition Enhancement Act
  • S 229
    DTC Act of 2025
  • HR 3789
    DTC Act of 2025
  • S 1414
    Expedited Access to Biosimilars Act
  • S 2099
    Restore Prescription Drugs Discount Act
  • HR 2450
    Prescription Drug Transparency and Affordability Act
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • HR 3269
    ETHIC Act
  • HR 2214
    DRUG Act
  • S 864
    HELP Copays Act
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • S 527
    Prescription Pricing for the People Act of 2025
  • HR 2041
    Hidden Fee Disclosure Act of 2025
  • S 1095
    Stop STALLING Act
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
 Lobbying activity 3
Medicare/Medicaid

H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act

Health Issues

S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act

Pharmacy

S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem